S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AIFF Firefly Neuroscience Inc

3.00

0.00 (0.00%)

Pre Market

Last Updated: 20:54:15

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Firefly Neuroscience (NASDAQ:AIFF)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Firefly Neuroscience Charts.

Firefly Neuroscience (NASDAQ:AIFF)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Firefly Neuroscience Charts.

Firefly Neuroscience Inc News

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
Friday 15 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event
Thursday 7 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 2 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 26 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 25 October 2024 (1 month ago) • Edgar (US Regulatory)

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
Monday 21 October 2024 (1 month ago) • GlobeNewswire Inc.

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
Thursday 17 October 2024 (1 month ago) • GlobeNewswire Inc.

Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
Wednesday 16 October 2024 (1 month ago) • GlobeNewswire Inc.

Firefly Neuroscience to Participate in Upcoming October Investor Conferences
Saturday 12 October 2024 (1 month ago) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 27 September 2024 (2 months ago) • Edgar (US Regulatory)

Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis
Friday 20 September 2024 (2 months ago) • GlobeNewswire Inc.

More Firefly Neuroscience Inc News Articles

Credit Suisse X-Links Si...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions